Delivery Order SPE2DR25D3201-SPE2DR26FT6AH
- Not listed
- The Defense Logistics Agency awarded a $7,111.95 delivery order to AmerisourceBergen Drug Corp for 90-count packages of Verapamil 80 mg tablets, with an ultimate completion date of January 22, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Verapamil 80 mg tablets (90-count units) with a ceiling value of $2,232.84. This non-competitive, firm fixed-price delivery order is set to be completed by December 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,687.44 to AmerisourceBergen Drug Corp for the supply of Verapamil 5 mg/2 mL vials on January 5, 2026, with completion targeted for January 6, 2026. This firm fixed price delivery order was awarded without a set-aside designation through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Verapamil 120 mg tablets. The $1,556.08 firm fixed-price contract has a completion date of June 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,455.09 to AmerisourceBergen Drug Corp for the supply of Verapamil 5 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was not set-aside and represents a competitively awarded procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Verapamil ER 120 mg tablets (100 count) under a firm fixed-price contract with a ceiling value of $3,660.42. The award was made on December 16, 2025, with an ultimate completion date of December 17, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,565.47 to AmerisourceBergen Drug Corp for the supply of Verapamil SR 120 mg capsules (100-count units) on January 13, 2026. This is a firm fixed-price, non-set-aside contract with a completion date of January 14, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Verapamil 5 mg/2 ml vials with a ceiling value of $2,177.96 under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and is scheduled for completion by January 15, 2026. The pharmaceutical product will be delivered from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Verapamil 5 mg/2 ml vials. The potential value of the contract is $1,494.93, with a completion date of February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Verapamil 80 mg tablets. The $1,781.15 firm fixed price contract has an ultimate completion date of August 21, 2024. The award is not associated with a set-aside. AmerisourceBergen, the prime contractor, has extensive federal contracting experience, including an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT6AHDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp for Verapamil 80 mg tablets (90-count) with a ceiling value of $7,198.33. This firm fixed-price, competitively awarded order was issued on January 28, 2026, with an ultimate completion date of January 29, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office. No set-aside designation was applied to this contract award. This delivery order represents a task order placed against Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant $999.999 billion indefinite delivery contract with the DLA Troop Support Medical through December 2031. This prime vendor agreement serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. The arrangement reflects Amerisourcebergen's critical role in the federal pharmaceutical supply chain for military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 1/27/26 |